6Lamping KG. Response of native and stimulated collateral vessels to serotonin. Am J Physiol, 1997,272 : H24.
7Hotta N, Nakamura J, Surnila Y, et al. Effects of the 5-HT2A receptor antagonist sarpogrelate in diabetic patients with complications: A pilot study. Clin Drug Invest, 1999,18 : 199-207.
10Diabetes Drafting Group. Prevalence of small and large vessel disease in diabetic patients from 14 centers. The WTO multinational study of vascular disease in diabetics. Diabetologia, 1985,28 ( Suppl ) : 615- 640.
3IsIam S, Hamarayan P, Cawich SO, et al. Epidemiology of diabetic foot infections in an eastern Canbbean population: a prospettive study[J]. Perm J, 2013,17(2):37-40.
4Sasaki H, Saiki A, Endo K, et al. Protective effects of efonidipine, a T- and L-type calium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy[ J ]. J Atheroscler Thromb, 2009,16( 5 ):568-575.
5Scuteri A, Tesauro M, Rizza S, et al. Endothelial function and arteria| stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome [ J ]. Nutr Metab Cardiovasc Dis, 2008,|8( 5 ): 349-356.
6Miqliacci R, Nasorri R, Ricciarini P, et al. Ankle-brachial index measured by palpation for the diagnoses of peripheral arterial disease [J]. Fame Pact, 2008,25(4): 228-232.
7American Diabetes Association. Standards of medical care in diabetes-2008 [ J ]. Diabetes Care, 2008,31 ( Suppl 1 ) :S 12-$54.
8Ghazanfar Q, Riehard B, Louis S, et al. Relationship between aortic atheroselerosis and non-invasive measures of arterial stiffness [J :. Atheroselerosis. 2007.195 ( 2 ): 190-194.
